Cita APA (7a ed.)

Leitner, K., Tsibulak, I., Wieser, V., Knoll, K., Reimer, D., Marth, C., . . . Zeimet, A. G. (2020). Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Leitner, Katharina, Irina Tsibulak, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth, Heidi Fiegl, y Alain G. Zeimet. Clinical Impact of EZH2 and Its Antagonist SMARCA4 in Ovarian Cancer. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Leitner, Katharina, et al. Clinical Impact of EZH2 and Its Antagonist SMARCA4 in Ovarian Cancer. Nature Portfolio, 2020.